0 Yorumlar
0 hisse senetleri
583 Views
0 önizleme
Site içinde arama yapın
Yeni insanlarla keşfedin, yeni bağlantılar oluşturmak ve yeni arkadaşlar edinmek
-
Please log in to like, share and comment!
-
Multiple Sclerosis Market: Competitive Developments in Neurological TherapeuticsPolaris Market Research has published its latest research report titled Multiple Sclerosis Market Share, Size Trends, Industry Analysis Report: By Drug Type (Immunosuppressants and Immunomodulators), By Route of Administration, and By Region – Market Forecast, 2026–2034. The report examines the global Multiple Sclerosis Market , covering its current size, market share, growth...0 Yorumlar 0 hisse senetleri 204 Views 0 önizleme
-
The Brain's Pharmacy: How Neurological Therapeutics Are Addressing Tardive DyskinesiaThe field of Neurological therapeutics encompasses a wide range of medications and interventions designed to treat disorders of the nervous system. Tardive dyskinesia, a movement disorder caused by long-term antipsychotic use, is one such condition that has benefited significantly from the development of new neurological therapeutics. The global market for tardive dyskinesia...0 Yorumlar 0 hisse senetleri 650 Views 0 önizleme
-
Japan CNS Therapeutics Market Forecast 2026 to 2035: Growth, Trends and OpportunitiesJapan Central Nervous System Therapeutics Market to Reach USD 57.0 Billion by 2035 According to Dimension Market Research, the Japan Central Nervous System Therapeutics Market is estimated to reach USD 22.0 billion in 2026 and is projected to expand to approximately USD 57.0 billion by 2035, registering a CAGR of 11.8% during 2026 to 2035. Increasing neurological disease prevalence, an aging...0 Yorumlar 0 hisse senetleri 45 Views 0 önizleme
-
Leukodystrophy Drug Market Size, Share, Trends & Forecast 2033According to the latest report published by Data Bridge Market Research, the Leukodystrophy Drug Market CAGR Value The global leukodystrophy drug market size was valued at USD 750.00 million in 2025 and is expected to reach USD 1,186.39 million by 2033, at a CAGR of 5.90% during the forecast period SWOT analysis and Porter’s Five Forces analysis are used to analyse...0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme